Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Chenjuan Shi, Li Tian, Wenwen Zheng, Yelei Zhu, Peilu Sun, Lele Liu, Wenkai Liu, Yanyan Song, Xianzhu Xia, Xianghong Xue & Xuexing Zheng. (2022) Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a Rabies Virus G protein confers long-lasting immune responses in mice and non-human primates. Emerging Microbes & Infections 11:1, pages 1439-1451.
Read now
Read now
Pingsen Zhao, Sharula Guo, Zhixiong Zhong, Songtao Yang & Xianzhu Xia. (2021) Quantitative characterization of the B cell receptor repertoires of human immunized with commercial rabies virus vaccine. Human Vaccines & Immunotherapeutics 17:8, pages 2538-2546.
Read now
Read now
A El-Sayed. (2018) Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms. International Journal of Veterinary Science and Medicine 6:1, pages 8-15.
Read now
Read now
Jiaojiao Peng, Shenghe Zhu, Lili Hu, Pingping Ye, Yifei Wang, Qin Tian, Mingzhu Mei, Hao Chen & Xiaofeng Guo. (2016) Wild-type rabies virus induces autophagy in human and mouse neuroblastoma cell lines. Autophagy 12:10, pages 1704-1720.
Read now
Read now
Manpreet Kaur, Rajni Garg, Samer Singh & Rakesh Bhatnagar. (2015) Rabies vaccines: where do we stand, where are we heading?. Expert Review of Vaccines 14:3, pages 369-381.
Read now
Read now
Articles from other publishers (41)
Michelle D. Zajac, Maria Teresa Ortega & Susan M. Moore. (2023) Development and Evaluation of an Enzyme-Linked Immunosorbent Assay Targeting Rabies-Specific IgM and IgG in Human Sera. Viruses 15:4, pages 874.
Crossref
Crossref
Rita V Burke, Pierantonio Russo, Michael Sicilia, William Wolowich, Novinyo Amega & Huy-Binh Nguyen. (2022) Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study. BMJ Open 12:4, pages e055411.
Crossref
Crossref
Rupal Ojha & Vijay Kumar Prajapati. (2021) Cognizance of posttranslational modifications in vaccines: A way to enhanced immunogenicity. Journal of Cellular Physiology 236:12, pages 8020-8034.
Crossref
Crossref
Gerrit J. Viljoen, Hermann Unger, Viskam Wijewardana & Ivancho Naletoski. 2021. Veterinary Vaccines. Veterinary Vaccines
119
134
.
Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Mukesh Doble & Sathiah Thennarasu. (2021) A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2. RSC Advances 11:33, pages 20006-20035.
Crossref
Crossref
Verena te Kamp, Virginia Friedrichs, Conrad M. Freuling, Ad Vos, Madlin Potratz, Antonia Klein, Luca M. Zaeck, Elisa Eggerbauer, Peter Schuster, Christian Kaiser, Steffen Ortmann, Antje Kretzschmar, Katharina Bobe, Michael R. Knittler, Anca Dorhoi, Stefan Finke & Thomas Müller. (2021) Comparable Long-Term Rabies Immunity in Foxes after IntraMuscular and Oral Application Using a Third-Generation Oral Rabies Virus Vaccine. Vaccines 9:1, pages 49.
Crossref
Crossref
Ting Li, Xin Wang & Hongbin Cheng. (2020) Meta-analysis of immunogenicity and safety of human rabies vaccination under Zagreb and Essen regimens. Journal of Comparative Effectiveness Research 9:7, pages 459-468.
Crossref
Crossref
Joseph R. Plummer & James P. McGettigan. (2019) Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses. PLOS Neglected Tropical Diseases 13:11, pages e0007800.
Crossref
Crossref
Xiang Wang, Zihao Fang, Jun Xiong, Kaiyan Yang, Yudan Chi, Xinying Tang, Li Ma, Renhuai Zhang, Fei Deng, Ke Lan & Dongming Zhou. (2019) A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge. Virology 536, pages 32-38.
Crossref
Crossref
Rebecca Poston, Richard Hill, Cynthia Allen, Warren Casey, Donna Gatewood, Robin Levis, Laurent Mallet, Dean Smith, Geetha Srinivas, Catrina Stirling & David Allen. (2019) Achieving scientific and regulatory success in implementing non-animal approaches to human and veterinary rabies vaccine testing: A NICEATM and IABS workshop report. Biologicals 60, pages 8-14.
Crossref
Crossref
Rohan Keshwara, Thomas Shiels, Elena Postnikova, Drishya Kurup, Christoph Wirblich, Reed F. Johnson & Matthias J. Schnell. (2019) Rabies-based vaccine induces potent immune responses against Nipah virus. npj Vaccines 4:1.
Crossref
Crossref
Rohan Keshwara, Katie R. Hagen, Tiago Abreu-Mota, Amy B. Papaneri, David Liu, Christoph Wirblich, Reed F. Johnson & Matthias J. Schnell. (2019) A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model. Journal of Virology 93:6.
Crossref
Crossref
Kevin L. Williams. 2019. Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems. Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems
17
52
.
Ilchan Song, Sol-Ah Park, Dalmuri Han, Hae Kyung Lee, Hyun Joo An & Kisung Ko. (2018) Expression, glycosylation, and function of an anti-rabies virus monoclonal antibody in tobacco and Arabidopsis plants. Horticulture, Environment, and Biotechnology 59:2, pages 285-292.
Crossref
Crossref
Prasad S. KulkarniJulia L. HurwitzEric A.F. SimõesPedro A. Piedra. (2018) Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field. Viral Immunology 31:2, pages 195-203.
Crossref
Crossref
Vahid AsgaryAlireza ShoariMajid Afshar MoayadMehdi Shafiee ArdestaniRazieh BigdeliLeila GhazizadehMohammad Sadeq KhosravyErfan PanahnejadAlireza JananiRouzbeh BasharMaliheh AbediReza Ahangari Cohan. (2018) Evaluation of G2 Citric Acid-Based Dendrimer as an Adjuvant in Veterinary Rabies Vaccine. Viral Immunology 31:1, pages 47-54.
Crossref
Crossref
Charles E. Rupprecht, Thirumeni Nagarajan & Hildegund Ertl. 2018. Plotkin's Vaccines. Plotkin's Vaccines
918
942.e12
.
Shannon L. Haley, Evgeni P. Tzvetkov, Andrew G. Lytle, Kishore R. Alugupalli, Joseph R. Plummer & James P. McGettigan. (2017) APRIL:TACI axis is dispensable for the immune response to rabies vaccination. Antiviral Research 144, pages 130-137.
Crossref
Crossref
Ludivine Chapat, Florence Hilaire, Jérome Bouvet, Daniel Pialot, Corinne Philippe-Reversat, Anne-Laure Guiot, Lydie Remolue, Jacques Lechenet, Christine Andreoni, Hervé Poulet, Michael J. Day, Karelle De Luca, Carine Cariou & Lionel Cupillard. (2017) Multivariate analysis of the immune response to a vaccine as an alternative to the repetition of animal challenge studies for vaccines with demonstrated efficacy. Veterinary Immunology and Immunopathology 189, pages 58-65.
Crossref
Crossref
Shannon L. Haley, Evgeni P. Tzvetkov, Samantha Meuwissen, Joseph R. Plummer & James P. McGettigan. (2017) Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis. Journal of Virology 91:8.
Crossref
Crossref
Karen L. Mansfield, Nick Andrews, Hooman Goharriz, Trudy Goddard, Lorraine M. McElhinney, Kevin E. Brown & Anthony R. Fooks. (2016) Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans. Vaccine 34:48, pages 5959-5967.
Crossref
Crossref
Anna Carolina A. Yendo, Fernanda de Costa, Samuel P. Cibulski, Thais F. Teixeira, Luana C. Colling, Mauricio Mastrogiovanni, Silvia Soulé, Paulo M. Roehe, Grace Gosmann, Fernando A. Ferreira & Arthur G. Fett-Neto. (2016) A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge. Vaccine 34:20, pages 2305-2311.
Crossref
Crossref
Charles E Rupprecht & Ivan V Kuzmin. (2015) Why we can prevent, control and possibly treat – but will not eradicate – rabies. Future Virology 10:5, pages 517-535.
Crossref
Crossref
Andrew G. Lytle, Shixue Shen & James P. McGettigan. (2015) Lymph Node but Not Intradermal Injection Site Macrophages Are Critical for Germinal Center Formation and Antibody Responses to Rabies Vaccination. Journal of Virology 89:5, pages 2842-2848.
Crossref
Crossref
Amy B. Papaneri, John G. Bernbaum, Joseph E. Blaney, Peter B. Jahrling, Matthias J. Schnell & Reed F. Johnson. (2015) Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine. Virus Research 197, pages 54-58.
Crossref
Crossref
Nicholas Johnson. (2015) Interplay between rabies virus and the mammalian immune system. World Journal of Clinical Infectious Diseases 5:4, pages 67.
Crossref
Crossref
Yuan Fang, Li Chen, Man-Qing Liu, Zheng-Gang Zhu, Ze-Rong Zhu & Quan Hu. (2014) Comparison of Safety and Immunogenicity of PVRV and PCECV Immunized in Patients with WHO Category II Animal Exposure: A Study Based on Different Age Groups. PLoS Neglected Tropical Diseases 8:12, pages e3412.
Crossref
Crossref
Ye Liu, Yingying Xu, Yue Tian, Chunying Chen, Chen Wang & Xingyu Jiang. (2014) Functional Nanomaterials Can Optimize the Efficacy of Vaccines. Small 10:22, pages 4505-4520.
Crossref
Crossref
Bruce A. Kimball, Maryanne Opiekun, Kunio Yamazaki & Gary K. Beauchamp. (2014) Immunization alters body odor. Physiology & Behavior 128, pages 80-85.
Crossref
Crossref
James E. Norton, Andrew G. Lytle, Shixue Shen, Evgeni P. Tzvetkov, Corin L. Dorfmeier & James P. McGettigan. (2014) ICAM-1-Based Rabies Virus Vaccine Shows Increased Infection and Activation of Primary Murine B Cells In Vitro and Enhanced Antibody Titers In-Vivo. PLoS ONE 9:1, pages e87098.
Crossref
Crossref
Sudhi Ranjan GargSudhi Ranjan Garg. 2014. Rabies in Man and Animals. Rabies in Man and Animals
75
87
.
Amy B. Papaneri, Christoph Wirblich, Wilfred E. Marissen & Matthias J. Schnell. (2013) Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: Implication for post-exposure treatment. Vaccine 31:49, pages 5897-5902.
Crossref
Crossref
Corin L. Dorfmeier, Shixue Shen, Evgeni P. Tzvetkov & James P. McGettigan. (2013) Reinvestigating the Role of IgM in Rabies Virus Postexposure Vaccination. Journal of Virology 87:16, pages 9217-9222.
Crossref
Crossref
Andrew G. Lytle, James E. NortonJrJr, Corin L. Dorfmeier, Shixue Shen & James P. McGettigan. (2013) B Cell Infection and Activation by Rabies Virus-Based Vaccines. Journal of Virology 87:16, pages 9097-9110.
Crossref
Crossref
Corin L. Dorfmeier, Evgeni P. Tzvetkov, Anthony Gatt & James P. McGettigan. (2013) Investigating the Role for IL-21 in Rabies Virus Vaccine-induced Immunity. PLoS Neglected Tropical Diseases 7:3, pages e2129.
Crossref
Crossref
Charles E. Rupprecht & Stanley A. Plotkin. 2013. Vaccines. Vaccines
646
668
.
Corin L. Dorfmeier, Andrew G. Lytle, Amber L. Dunkel, Anthony Gatt & James P. McGettigan. (2012)
Protective Vaccine-Induced CD4
+
T Cell-Independent B Cell Responses against Rabies Infection
. Journal of Virology 86:21, pages 11533-11540.
Crossref
Crossref
Judith M. Fontana, Elizabeth Alexander & Mirella Salvatore. (2012) Translational research in infectious disease: current paradigms and challenges ahead. Translational Research 159:6, pages 430-453.
Crossref
Crossref
M.J. Warrell. (2012) Current rabies vaccines and prophylaxis schedules: Preventing rabies before and after exposure. Travel Medicine and Infectious Disease 10:1, pages 1-15.
Crossref
Crossref
Sigfrido Burgos-Cáceres. (2011) Canine Rabies: A Looming Threat to Public Health. Animals 1:4, pages 326-342.
Crossref
Crossref
Emily A. Gomme, Celestine N. Wanjalla, Christoph Wirblich & Matthias J. Schnell. 2011. Research Advances in Rabies. Research Advances in Rabies
139
164
.